Sinew Pharma Inc. (TPEX:6634)
Taiwan
· Delayed Price · Currency is TWD 33.60
-0.10 (-0.30%)
Mar 10, 2026, 12:19 PM CST
Sinew Pharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -141.91 | -150.37 | -170.92 | -140.18 | -91.58 | -82.01 | Upgrade
|
| Depreciation & Amortization | 28.5 | 30.21 | 28.95 | 22.78 | 22.59 | 21.74 | Upgrade
|
| Other Amortization | 0.09 | 0.1 | 0.03 | 0.03 | 0.06 | 0.12 | Upgrade
|
| Stock-Based Compensation | 22.86 | 20.16 | 18 | 16.71 | 12.1 | 2.08 | Upgrade
|
| Other Operating Activities | -1.49 | -0.99 | -0.86 | -0.45 | -0.41 | 0.01 | Upgrade
|
| Change in Accounts Receivable | 2.39 | 0.42 | 0.23 | - | 0.15 | -0.15 | Upgrade
|
| Change in Accounts Payable | -5.43 | -3.72 | 8.68 | - | - | - | Upgrade
|
| Change in Unearned Revenue | - | - | - | -0.33 | 0.85 | - | Upgrade
|
| Change in Other Net Operating Assets | -2.01 | -1.89 | -2.16 | 7.67 | -1.06 | -1.05 | Upgrade
|
| Operating Cash Flow | -97 | -106.08 | -118.05 | -93.76 | -57.32 | -59.26 | Upgrade
|
| Capital Expenditures | -0.47 | -0.18 | -7.21 | -5.23 | -2.18 | -1.8 | Upgrade
|
| Sale (Purchase) of Intangibles | -1.09 | -1.15 | -0.24 | -0.66 | -3.69 | -0.9 | Upgrade
|
| Investment in Securities | 31.8 | -9 | 35.8 | -213 | -640 | -251.5 | Upgrade
|
| Other Investing Activities | -4.72 | -6.36 | -2.15 | -2.26 | -2.7 | -2.53 | Upgrade
|
| Investing Cash Flow | 25.52 | -16.69 | 26.2 | -221.15 | -648.56 | -256.72 | Upgrade
|
| Long-Term Debt Repaid | - | -6.46 | -6.1 | -2.76 | -2.29 | -1.84 | Upgrade
|
| Net Debt Issued (Repaid) | -6.68 | -6.46 | -6.1 | -2.76 | -2.29 | -1.84 | Upgrade
|
| Issuance of Common Stock | 0.65 | 3.82 | 18.08 | 13.17 | 1,213 | 111.93 | Upgrade
|
| Financing Cash Flow | -6.03 | -2.65 | 11.98 | 10.41 | 1,210 | 110.09 | Upgrade
|
| Net Cash Flow | -77.51 | -125.42 | -79.87 | -304.49 | 504.35 | -205.9 | Upgrade
|
| Free Cash Flow | -97.47 | -106.26 | -125.26 | -98.99 | -59.5 | -61.06 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -30178.66% | -955.19% | -13217.10% | Upgrade
|
| Free Cash Flow Per Share | -1.37 | -1.49 | -1.78 | -1.43 | -1.00 | -1.23 | Upgrade
|
| Cash Interest Paid | 0.2 | 0.41 | 0.78 | 0.28 | 0.15 | 0.27 | Upgrade
|
| Cash Income Tax Paid | 0.3 | - | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -57.2 | -63.29 | -71.93 | -51.5 | -34.31 | -264.67 | Upgrade
|
| Unlevered Free Cash Flow | -57.07 | -63.03 | -71.44 | -51.33 | -34.22 | -264.5 | Upgrade
|
| Change in Working Capital | -5.05 | -5.19 | 6.75 | 7.35 | -0.07 | -1.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.